DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?

This publication has 21 references indexed in Scilit:

• Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions
  British Journal of Cancer, 1989
• ENHANCEMENT OF MITOMYCIN-C CYTO-TOXICITY TO HYPOXIC TUMOR-CELLS BY DICOUMAROL INVIVO AND INVITRO
  1985
• PORFIROMYCIN AS A BIOREDUCTIVE ALKYLATING AGENT WITH SELECTIVE TOXICITY TO HYPOXIC EMT6 TUMOR-CELLS INVIVO AND INVITRO
  1985
• Induction of dna damage by menadione (2-methyl-1,4-naphthoquinone) in primary cultures of rat hepatocytes
  Biochemical Pharmacology, 1984
• Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase.
  Journal of Biological Chemistry, 1984
• The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells.
  Journal of Biological Chemistry, 1982
• DT-diaphorase as a quinone reductase: A cellular control device against semiquinone and superoxide radical formation
  Archives of Biochemistry and Biophysics, 1982
• NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
  Proceedings of the National Academy of Sciences, 1979
• One-electron-transfer reactions in biochemical systems V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase)
  Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1970
• WALKER CARCINOSARCOMA 256 IN STUDY OF ANTICANCER AGENTS .I. METHOD FOR SIMULTANEOUS ASSESSMENT OF THERAPEUTIC VALUE AND TOXICITY
  1966